| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/13/2002 | CA2431032A1 6-0-carbamoyl ketolide derivatives of erythromycin useful as antibacterials |
| 06/13/2002 | CA2430993A1 G-protein coupled receptors |
| 06/13/2002 | CA2430966A1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 06/13/2002 | CA2430844A1 Aryl ether substituted imidazoquinolines |
| 06/13/2002 | CA2430558A1 Proteins and nucleic acids encoding same |
| 06/13/2002 | CA2430376A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors |
| 06/13/2002 | CA2430206A1 Screening method for identifying compounds that selectively induce interferon alpha |
| 06/13/2002 | CA2429728A1 Tyrosine kinase inhibitors |
| 06/13/2002 | CA2429641A1 Kinases and phosphatases |
| 06/13/2002 | CA2429258A1 Piperidine/piperazine-type inhibitors of p38 kinase |
| 06/13/2002 | CA2427820A1 Method of producing biospecific molecules by protein trans-splicing |
| 06/13/2002 | CA2427430A1 Methods for stimulating nervous system regeneration and repair by inhibition phosphodiesterase type 4 |
| 06/12/2002 | EP1213351A2 Nucleic acid enzymes acquiring an activity for cleaving a target RNA by recognising another molecule |
| 06/12/2002 | EP1213298A1 Antibiotics GE 23077, pharmaceutically acceptable salts and compositions, and use thereof |
| 06/12/2002 | EP1213289A1 N-benzenesulfonyl L-proline compounds as bradykinin antagonists |
| 06/12/2002 | EP1213032A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 06/12/2002 | EP1213029A1 Combination therapy for eradicating detectable HCV-RNA in antiviral treatment naive patients having chronic hepatitis C infection |
| 06/12/2002 | EP1213025A1 Cosmetic and/or dermopharmaceutical composition containing extracts obtained from the leaves of Argania spinosa |
| 06/12/2002 | EP1213015A1 Oral pharmaceutical composition with delayed release of proton pump inhibitors |
| 06/12/2002 | EP1212446A2 Viral replicons and viruses dependent on inducing agents |
| 06/12/2002 | EP1212422A2 Human ctla-4 antibodies and their uses |
| 06/12/2002 | EP1212408A2 Bryostatins, bryopyrans and polyketides: compositions and methods |
| 06/12/2002 | EP1212407A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 06/12/2002 | EP1212366A2 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 06/12/2002 | EP1212363A2 Il-16 antagonists |
| 06/12/2002 | EP1212362A2 Card proteins involved in cell death regulation |
| 06/12/2002 | EP1212358A2 Synthetic papillomavirus genes optimized for expression in human cells |
| 06/12/2002 | EP1212349A1 Recombinant subunit vaccine |
| 06/12/2002 | EP1212344A1 B7-like polynucleotides, polypeptides, and antibodies |
| 06/12/2002 | EP1212336A2 Spherical telithromycin clusters, method for the production and use thereof in the preparation of pharmaceutical forms |
| 06/12/2002 | EP1212331A1 28-epirapalogs |
| 06/12/2002 | EP1212328A1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 06/12/2002 | EP1212327A2 Pyrazolopyrimidines as therapeutic agents |
| 06/12/2002 | EP1212326A1 PYRROLO 2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS |
| 06/12/2002 | EP1212317A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 06/12/2002 | EP1212309A1 Caspase inhibitor |
| 06/12/2002 | EP1212296A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 06/12/2002 | EP1212120A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 06/12/2002 | EP1212094A2 Delivery of antimicrobial toxins |
| 06/12/2002 | EP1212093A2 Use of emu oil as a carrier for antifungal, antibacterial and antiviral medications |
| 06/12/2002 | EP1212087A1 Methods and compositions utilizing rad51 |
| 06/12/2002 | EP1212084A2 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 06/12/2002 | EP1212083A1 Oral recombinant lactobacilli vaccines |
| 06/12/2002 | EP1212082A1 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| 06/12/2002 | EP1212080A2 The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses |
| 06/12/2002 | EP1212079A1 Topical treatment of streptococcal infections |
| 06/12/2002 | EP1212074A1 Hybrid peptides modulate the immune response |
| 06/12/2002 | EP1212072A1 Pharmaceutical composition that contains eucalyptus and orange oil |
| 06/12/2002 | EP1212069A2 Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof |
| 06/12/2002 | EP1212063A2 Topical azathioprine for the treatment of oral autoimmune diseases |
| 06/12/2002 | EP1212058A1 Topical treatment for prevention of ocular infections |
| 06/12/2002 | EP1212049A2 Use of thiamphenicol for thetreatment of chlamydia pneumoniae infections |
| 06/12/2002 | EP1212045A1 A vaccine composition and method of using the same |
| 06/12/2002 | EP1212043A2 Composition to be administered through mucous membrane |
| 06/12/2002 | EP1056722B1 Bisulfate salt of hiv protease inhibitor |
| 06/12/2002 | EP1044000B1 Combination therapy for the treatment of aids |
| 06/12/2002 | EP1039922B1 Improved interferon polymer conjugates |
| 06/12/2002 | EP1032571B1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 06/12/2002 | EP1007059A4 Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria |
| 06/12/2002 | EP0968222B1 Novel erythromycin derivatives, method of preparation and application as medicines |
| 06/12/2002 | EP0929517B1 Hydroxamic acid derivatives |
| 06/12/2002 | EP0880533B1 Triazole derivatives useful in therapy |
| 06/12/2002 | EP0877739B1 Azole compounds endowed with antimycotic activity for human and veterinary use |
| 06/12/2002 | EP0873362B1 PROCESS FOR ISOLATING IgG AND IgA |
| 06/12/2002 | EP0822941B1 Monoclonal antibodies against hiv-1 and vaccines made thereof |
| 06/12/2002 | EP0817864B1 Method for the diagnosis of crohn's disease and ulcerative colitis |
| 06/12/2002 | EP0768881B1 Anti-hiv triple combination comprising zidovudine, lamivudine and loviride |
| 06/12/2002 | EP0759774B1 Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein product and antibiotic |
| 06/12/2002 | EP0749317B1 Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
| 06/12/2002 | EP0734391B1 Pna-dna-pna chimeric macromolecules |
| 06/12/2002 | EP0688211B1 Thalidomide for inhibition of angiogenesis |
| 06/12/2002 | EP0678035B1 Vaccine preparations |
| 06/12/2002 | EP0669833B1 Type ii tgf-beta-binding receptor fragment as therapeutic agent |
| 06/12/2002 | EP0574395B1 Cytokine immunoconjugates |
| 06/12/2002 | CN1353764A Method for selecting improved vectors |
| 06/12/2002 | CN1353713A Purine inhibitors of cyclin dependent kinase 2 and IK B-alpha |
| 06/12/2002 | CN1353710A 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
| 06/12/2002 | CN1353709A Bicyclic oxazolidinones as antibacterial agents |
| 06/12/2002 | CN1353706A Integrin receptor ligands |
| 06/12/2002 | CN1353704A 取代吡唑化合物 A substituted pyrazole compound |
| 06/12/2002 | CN1353695A Heterocyclically substituted benzimidazoles, production and application thereof |
| 06/12/2002 | CN1353690A Bradykinin receptor antagonists |
| 06/12/2002 | CN1353609A Amide substituted imidazoquinolines |
| 06/12/2002 | CN1353607A Improved pharmaceutical formulations |
| 06/12/2002 | CN1353606A IL-8 receptor antagonists |
| 06/12/2002 | CN1353575A i(in Vitro) induction of antigen-specific T-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens |
| 06/12/2002 | CN1353574A Disinfecting composition based on H2O2 acids and metal ions |
| 06/12/2002 | CN1353573A Anti-inflammatory therapy for inflammatory mediated infection |
| 06/12/2002 | CN1353114A Human papillomavirus 11L1-E7 recombination protein and its application |
| 06/12/2002 | CN1353108A Process for preparing fluconazole as antifungal medicine |
| 06/12/2002 | CN1352978A Medicine 'Shenfeishu' for treating nephrosis and lung disease and its preparing process |
| 06/12/2002 | CN1352969A Universal surgical plaster |
| 06/12/2002 | CN1352964A Powdered medicine for treating pulmonary tuberculosis |
| 06/12/2002 | CN1352952A Prescription of Pugonglian Herbal medicine |
| 06/12/2002 | CN1352951A Prescription of Daolu powder |
| 06/12/2002 | CN1352949A Enterior-applied powdered Chinese medicine for treating AIDS and its application |
| 06/12/2002 | CN1352942A Medicine for treating tuberculosis |
| 06/11/2002 | USRE37741 Purified nontypable Haemophilus influenzae P5 protein as a vaccine for nontypable Haemophilus influenzae infection |
| 06/11/2002 | US6404779 System and method of disharmonic frequency multiplexing |
| 06/11/2002 | US6403830 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |